Ingredients

(Image: Getty/Anghi)

GSK gets first approval for two-drug HIV treatment

By Ben Hargreaves

GSK’s Dovato is approved by the US FDA for the treatment of individuals with HIV with no previous antiretroviral therapy, in a first for a two-drug, fixed-dose, complete regimen.

(Image: Getty/Светлана Зайцева)

US farm bill a boon for pharma?

By Flora Southey

If approved by President Trump, the five-year farm bill – which removes hemp from the federal controlled substance list – could help advance cannabinoid R&D, says Nexien Biopharma.